Hyperfine Newsroom

Wells Fargo Maintains Hyperfine(HYPR.US) With Hold Rating, Maintains Target Price $1.2

Futu NewsNov 13 19:31

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)

TipRanksAug 12 01:04

B. Riley Adjusts Price Target on Hyperfine to $1.50 From $1.30, Maintains Buy Rating

MT NewswiresAug 9 21:12

Hyperfine Analyst Ratings

BenzingaMar 22 23:25

Jefferies Initiates Coverage On Hyperfine With Hold Rating, Announces Price Target of $1.25

BenzingaNov 30, 2023 21:07

Hyperfine Analyst Ratings

BenzingaNov 30, 2023 21:02

Hyperfine Analyst Ratings

BenzingaAug 15, 2023 22:55

B. Riley Lifts Hyperfine's Price Target to $3.50 From $2.50 After Higher-Than-Expected Q2 Results, Keeps Buy Rating

MT NewswiresAug 15, 2023 19:45

B.Riley Financial Reaffirms Their Buy Rating on Hyperfine (HYPR)

TipRanksAug 15, 2023 14:45

B.Riley Financial Remains a Buy on Hyperfine (HYPR)

TipRanksMay 13, 2023 01:45

B. Riley Adjusts Price Target on Hyperfine to $2.50 From $3.50 After Softer-Than-Expected Q4 Results, 2023 Guidance; Keeps Buy Rating

MT NewswiresMar 22, 2023 20:03

B. Riley Securities Maintains Buy on Hyperfine, Lowers Price Target to $2.5

BenzingaMar 22, 2023 19:34

Hyperfine (HYPR) Gets a Buy From B.Riley Financial

TipRanksMar 22, 2023 10:07